FMR LLC 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 11:00 am Sale | 2026-03-31 | 13G | ARRIVENT BIOPHARMA INC AVBP | FMR LLC | 3,016,132 6.800% | -391,417 (-11.49%) | Filing |
| 2025-11-05 11:26 am Purchase | 2025-09-30 | 13G | ARRIVENT BIOPHARMA INC AVBP | FMR LLC | 3,407,549 8.400% | 1,287,854 (+60.76%) | Filing |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | ARRIVENT BIOPHARMA INC AVBP | FMR LLC | 2,119,695 6.311% | 2,119,695 (New Position) | Filing |